EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

MptpB Inhibitor Improves the Action of Antibiotics against Mycobacterium tuberculosis and Nontuberculous Mycobacterium avium Infections

Pablo Rodríguez-Fernández iD, Laure Botella, Jennifer S Cavet, Jose Domínguez, Maximiliano G Gutierrez iD, Colin J Suckling, Fraser J Scott iD, Lydia Tabernero iD

ACS Infectious Diseases · 2024

DOI: 10.1021/acsinfecdis.3c00446 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2024. Verfasst von Pablo Rodríguez-Fernández und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, M13 9PT …. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Tuberculosis. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Medical Research Council, Francis Crick Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisTuberculosisHumansAnti-Bacterial AgentsBacterial ProteinsProtein Tyrosine PhosphatasesNontuberculous Mycobacteria

Stichwörter der Autor:innen

Galleria mellonellaLAMP-1 lysosomal markerMptpBMycobacterium aviumMycobacterium tuberculosiscombination of antibiotics

Substanzen

Anti-Bacterial AgentsBacterial ProteinsProtein Tyrosine Phosphatases

Autor:innen und Institutionen

  • School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, M13 9PT Manchester, U.K.
  • Host Pathogen Interactions in Tuberculosis Laboratory, The Francis Crick Institute, NW1 1AT London, U.K.
  • Lydia Becker Institute for Immunology and Inflammation, University of Manchester, M13 9PT Manchester, U.K.
  • Institut d'Investigació Germans Trias i Pujol, CIBER Enfermedades Respiratorias (CIBERES), Universitat Autònoma de Barcelona, 08916 Barcelona, Spain.
  • Department of Pure and Applied Chemistry, University of Strathclyde, 295 Cathedral Street, G1 1XL Glasgow, U.K.

ORCID-Profile: Pablo Rodríguez-Fernández, Maximiliano G Gutierrez, Fraser J Scott, Lydia Tabernero

Förderung

  • Wellcome Trust
  • Medical Research Council
  • Francis Crick Institute
  • European Regional Development Fund
  • Chief Scientist Office
  • Instituto de Salud Carlos III
  • Horizon 2020 Framework Programme
  • Biotechnology and Biological Sciences Research Council

Zitieren

APA

Rodríguez-Fernández, P., Botella, L., Cavet, J. S., Domínguez, J., Gutierrez, M. G., Suckling, C. J., Scott, F. J., & Tabernero, L. (2024). MptpB Inhibitor Improves the Action of Antibiotics against Mycobacterium tuberculosis and Nontuberculous Mycobacterium avium Infections. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.3c00446

Vancouver

Rodríguez-Fernández P, Botella L, Cavet JS, Domínguez J, Gutierrez MG, Suckling CJ, et al. MptpB Inhibitor Improves the Action of Antibiotics against Mycobacterium tuberculosis and Nontuberculous Mycobacterium avium Infections. ACS Infectious Diseases. 2024. doi:10.1021/acsinfecdis.3c00446

BibTeX
@article{RodrguezFernndez2024,
  author = {Rodríguez-Fernández, Pablo and Botella, Laure and Cavet, Jennifer S and Domínguez, Jose and Gutierrez, Maximiliano G and Suckling, Colin J and Scott, Fraser J and Tabernero, Lydia},
  title = {MptpB Inhibitor Improves the Action of Antibiotics against Mycobacterium tuberculosis and Nontuberculous Mycobacterium avium Infections},
  journal = {ACS Infectious Diseases},
  year = {2024},
  doi = {10.1021/acsinfecdis.3c00446}
}
Kostenlos starten →